FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

AbbVie Synthroid Recall

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0

AbbVie Inc. · North Chicago, IL

Risk level
Class III
Reported by FDA
Nov 15, 2023
Recall ID
D-0088-2024
Check your lot numberHow we source this data

Summary

AbbVie recalled Synthroid starting Oct 17, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0088-2024 on Nov 15, 2023. Reason: Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose. Status: Ongoing.

Why it was recalled

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Product description

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Lot numbers, UPCs & expiration codes

Lot # 1187435 exp date: 02/2024

Where it was sold

Distributed in the US. No government or foreign consignees.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0088-2024
Classification
Class III
Status
Ongoing
Recall initiated
Oct 17, 2023
FDA report date
Nov 15, 2023
Quantity
864 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc.

Original FDA data

Every field from FDA enforcement report D-0088-2024, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Ongoing
Country
United States
Event ID
93202
Address
1 N Waukegan Rd
Code information
Lot # 1187435 exp date: 02/2024
Postal code
60064-1802
Report date
Nov 15, 2023
Product type
Drugs
Recall number
D-0088-2024
Classification
Class III
Recalling firm
AbbVie Inc.
Product quantity
864 cartons
Reason for recall
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
Distribution pattern
Distributed in the US. No government or foreign consignees.
Recall initiation date
Oct 17, 2023
Initial firm notification
Letter
Center classification date
Nov 5, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0088-2024, published Nov 15, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls